PDF
ePub
Citation
Print
Abstract
In the Diabetes Care Guidelines of the Korean Diabetes Association in 2015, the use of continuous glucose monitoring in patients with type 1 diabetes who undergo multiple insulin therapy or insulin pump therapy is helpful in controlling blood sugar and monitoring blood glucose level when fluctuation is high or hypoglycemia is frequent. Recently, the American Diabetes Association published in the 2019 Standard of Care in Diabetes in the new diabetes technology part the criteria for use and methods of the continuous blood glucose meter. Continuous and real-time blood glucose meters emphasize the importance of education prior to use. In particular, the real-time blood glucose meter is a useful device for prevention of hypoglycemia in type 1 diabetes in children and adults. The purpose of this study is to summarize the contents of the continuous blood glucose measurement part of the 2019 Standard of Care in Diabetes.
REFERENCES
1.Hirsch IB. Hypoglycemia and the hypoglycemic unawareness syndrome. Diabetes Technol Ther. 2000. 2(Suppl 1):S81–7.
2.Korean Diabetes Association. Treatment guideline for diabetes 2015. Seoul: Korean Diabetes Association;2015.
3.American Diabetes Association. 7. Diabetes technology: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019. 42(Suppl 1):S71–80.
4.Battelino T., Conget I., Olsen B., Schütz-Fuhrmann I., Hommel E., Hoogma R., Schierloh U., Sulli N., Bolinder J. SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012. 55:3155–62.
5.Deiss D., Bolinder J., Riveline JP., Battelino T., Bosi E., Tubiana-Rufi N., Kerr D., Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006. 29:2730–2.
6.O’Connell MA., Donath S., O’Neal DN., Colman PG., Ambler GR., Jones TW., Davis EA., Cameron FJ. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009. 52:1250–7.
7.Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Tamborlane WV., Beck RW., Bode BW., Buckingham B., Chase HP., Clemons R., Fiallo-Scharer R., Fox LA., Gilliam LK., Hirsch IB., Huang ES., Kollman C., Kowalski AJ., Laffel L., Lawrence JM., Lee J., Mauras N., O’Grady M., Ruedy KJ., Tansey M., Tsalikian E., Weinzimer S., Wilson DM., Wolpert H., Wysocki T., Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008. 359:1464–76.
8.Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Beck RW., Buckingham B., Miller K., Wolpert H., Xing D., Block JM., Chase HP., Hirsch I., Kollman C., Laffel L., Lawrence JM., Milaszewski K., Ruedy KJ., Tamborlane WV. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009. 32:1947–53.
9.Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2010. 33:17–22.
10.Battelino T., Phillip M., Bratina N., Nimri R., Oskarsson P., Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011. 34:795–800.
11.Riddlesworth T., Price D., Cohen N., Beck RW. Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections. Diabetes Ther. 2017. 8:947–51.
12.Lind M., Polonsky W., Hirsch IB., Heise T., Bolinder J., Dahlqvist S., Schwarz E., Ólafsdóttir AF., Frid A., Wedel H., Ahlén E., Nyström T., Hellman J. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA. 2017. 317:379–87.
13.Sequeira PA., Montoya L., Ruelas V., Xing D., Chen V., Beck R., Peters AL. Continuous glucose monitoring pilot in low-income type 1 diabetes patients. Diabetes Technol Ther. 2013. 15:855–8.
14.Tumminia A., Crimi S., Sciacca L., Buscema M., Frittitta L., Squatrito S., Vigneri R., Tomaselli L. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. Diabetes Metab Res Rev. 2015. 31:61–8.
15.Bolinder J., Antuna R., Geelhoed-Duijvestijn P., Kröger J., Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016. 388:2254–63.
16.Beck RW., Riddlesworth TD., Ruedy K., Ahmann A., Haller S., Kruger D., McGill JB., Polonsky W., Price D., Aronoff S., Aronson R., Toschi E., Kollman C., Bergenstal R. DIAMOND Study Group. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017. 167:365–74.
17.Ehrhardt NM., Chellappa M., Walker MS., Fonda SJ., Vigersky RA. The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus. J Diabetes Sci Technol. 2011. 5:668–75.
18.Feig DS., Donovan LE., Corcoy R., Murphy KE., Amiel SA., Hunt KF., Asztalos E., Barrett JFR., Sanchez JJ., de Leiva A., Hod M., Jovanovic L., Keely E., McManus R., Hutton EK., Meek CL., Stewart ZA., Wysocki T., O’Brien R., Ruedy K., Kollman C., Tomlinson G., Murphy HR. CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017. 390:2347–59.
19.Beck RW., Riddlesworth T., Ruedy K., Ahmann A., Bergenstal R., Haller S., Kollman C., Kruger D., McGill JB., Polonsky W., Toschi E., Wolpert H., Price D. DIAMOND Study Group. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017. 317:371–8.
20.Palylyk-Colwell E., Ford C. Flash glucose monitoring system for diabetes. Available from:. https://www.ncbi.nlm.nih.gov/books/NBK476439. (updated 2017 Jun 01).
XML Download